Page last updated: 2024-11-07

8-fluorociprofloxacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8-fluorociprofloxacin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122848
CHEMBL ID15549
SCHEMBL ID8616936
MeSH IDM0270405

Synonyms (19)

Synonym
3-quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6,8-difluoro-4-oxo-7-(1-piperazinyl)-
8-fluorociprofloxacin
brn 3632527
1-cyclopropyl-6,8-difluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
at 3970
1-cyclopropyl-6,8-difluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid
amq1
1-cyclopropyl-6,8-difluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
94242-53-2
1-cyclopropyl-6,8-difluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
CHEMBL15549 ,
1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
CZXWNPNFWRABAP-UHFFFAOYSA-N
1-cyclopropyl-6,8-difluoro- 7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6,8-difluoro7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6,8-difluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
SCHEMBL8616936
DTXSID30241222
bdbm50227277
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (16)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.505710.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.497310.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.498810.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.504610.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.506510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.505710.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
GABA theta subunitRattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)IC50 (µMol)32.06000.00010.507510.0000AID71980; AID71981
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (154)

Assay IDTitleYearJournalArticle
AID133761Maximum tolerance dose was measured for phototoxic skin reaction by po administration1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID201952In vivo efficacy (s.c.) against Streptococcus pneumoniae SV-1 in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID151536Tested in vitro against Pseudomonas aeruginosa IFO3445 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID117654In vivo potency against Escherichia coli vogel using mouse protection assay when given perorally1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID163916Minimum inhibitory concentration (MIC) against gram negative bacteria Pseudomonas aeruginosa UI-18.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID207974Minimum inhibitory concentration against Staphylococcus aureus H228 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID209462In vitro antibacterial activity against Streptococcus pyogenes A651990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID54107Minimum inhibitory concentration required to inhibit DNA gyrase supercoiling.1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID117674Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (po)1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID209061In vitro antibacterial activity against Streptococcus epidermis 81990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID71794Percentage of GABA-induced chloride currents with 10e-4 M 4-biphenylacetic acid1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID198020Antibacterial activity was determined against gram positive organism, Streptococcus faecalis (MGH-2)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID201400Minimum inhibition concentration against Staphylococcus aureus MRSA strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID114066Oral efficacy against Pseudomonas aeruginosa 12 on Systemic Infections in Mice1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID117692The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pyogenes after sc administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID202111In vivo efficacy (orally) against Streptococcus pyogenes C-203 in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID198344Tested in vitro against Staphylococcus aureus IID803 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID117675Median protective dose against Escherichia coli, determined in acute, lethal systemic infection in female charles river CD-1 mice (sc)1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID151052Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa UI-181991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID70290In vivo protection against gram-positive Escherichia coli vogel in mouse after subcutaneous administration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID117660In vivo potency against Streptococcus pneumoniae using mouse protection assay following s.c. administration.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID151535Tested in vitro against Pseudomonas aeruginosa E-2 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID110153Percentage of mice with convulsion with compound alone at 400 mg/kg1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID198174Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae (SV-1)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID198342Tested in vivo against Staphylococcus aureus IID803 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID202110In vivo efficacy (s.c.) against Streptococcus pyogenes C-203 in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID56593Number of mice which show positive phototoxic reaction in 5 mice1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID201953In vivo efficacy (orally) against Streptococcus pneumoniae SV-1 in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID93881Minimum inhibitory concentration against Klebsiella pneumoniae MGH-2 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID117652In vivo oral protective dose was determined in female charles river CD-1 mice infected with Escherichia coli (vogel)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID69340Minimum inhibitory concentration against Escherichia coli vogel in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID161378Minimum inhibitory concentration (MIC) against gram negative bacteria Prot. rettgeri M-1771.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID69826Tested in vitro against Escherichia coli NIHJ JC-2 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID203167Tested in vitro against Serratia marcescens IAM1184 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID69619Antibacterial activity against Escherichia coli H5601988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID117689The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae after peroral administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID117664In vivo subcutaneous protective dose was determined in female charles river CD-1 mice infected with Escherichia coli (vogel)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID94133In vitro antibacterial activity against Klebsiella pneumoniae (A 9664)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID64251Antibacterial activity was determined against gram negative organism, Escherichia coli vogel1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID69626Antibacterial activity against Escherichia coli Vogel1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID117691The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pyogenes after peroral administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID205946Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pyogenes C-203.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID163093Minimum inhibitory concentration against Pseudomonas aeruginosa UI-18 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID198176Antibacterial activity was determined against gram positive organism, Streptococcus pneumoniae SV-11991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID103832In vitro antibacterial activity against Morganella morganii (A 15153)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID205944Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus faecalis MGH-2.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID150908Antibacterial activity was determined against gram negative organism, Pseudomonas aeruginosa (UI-18)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID209126Antibacterial activity against Streptococcus pyogenes C2031988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID198316Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes (C203)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID151055In vitro antibacterial activity against Pseudomonas aeruginosa (A 9843)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID209247Minimum inhibitory concentration against Streptococcus faecalis MGH-2 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID200230Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (H228)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID230838MIC ratio measured as the mean MICs of gram-negative bacteria1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID74734MIC ratio measured as the mean MICs of gram-positive bacteria1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID202106Minimum inhibition concentration against Streptococcus pneumoniae Type I strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID74856Compound evaluated in vitro against five gram-positive bacterial strains and geometric means of the minimum inhibitory concentrations (MIC) reported.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID71793Percentage of GABA-induced chloride currents with 10 e-5 M 4-biphenylacetic acid1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID163914In vivo efficacy (s.c.) against Pseudomonas aeruginosa in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID198317Antibacterial activity was determined against gram positive organism, Streptococcus pyogenes C2031991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID57388Minimum inhibitory concentration against Escherichia coli DNA-gyrase in supercoiling assay1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID63899Antibacterial activity against gram negative organism, Escherichia cloacae (MA2646)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID68191In vitro antibacterial activity against Enterobacter cloacae 9631990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID117665In vivo subcutaneous protective dose was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID163915In vivo efficacy (orally) against Pseudomonas aeruginosa in mouse protection test1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID200881Tested in vitro against Salmonella Typhimurium IID971 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID94123Antibacterial activity was determined against gram negative organism, K. pneumoniae (MGH-2)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID163554Tested in vitro against Proteus vulgaris OX-19 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID71980Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID68013Antibacterial activity against Enterobacter cloacae MA26461988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID96403In vitro antibacterial activity against gram-negative Klebsiella pneumoniae2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID114068Oral efficacy against Streptococcus pyogenes A65 on Systemic Infections in Mice1990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID64405The in vivo potency was determined in female charles river CD-1 mice infected with Escherichia coli after sc administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID70704Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli H-560.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID69339Minimum inhibitory concentration against Escherichia coli H560 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID68519Minimum inhibitory concentration against Enterobacter cloacae HA 2646 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID117657In vivo potency against Staphylococcus aureus using mouse protection assay following s.c. administration.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID65384Minimum inhibition concentration against Enterococcus faecalis LS-101 strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID203326In vitro antibacterial activity against Serratia marcescens S-91990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID209067Antibacterial activity against Streptococcus faecalis MGH-21988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID95531Minimum inhibitory concentration (MIC) against gram negative bacteria Klebsiella pneumoniae MGH-2.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID70705Minimum inhibitory concentration (MIC) against gram negative bacteria Escherichia coli Vogel.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID64394In vitro antibacterial activity against Enterobacter cloacae (A 9656)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID64076In vitro antibacterial activity against Escherichia coli (A 15119)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID203042In vitro antibacterial activity against gram-negative Shigella boydii2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID117690The in vivo potency was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae after sc administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID206034Tested in vitro against Staphylococcus epidermidis IAM12896 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID198021Antibacterial activity was determined against gram positive organism, Streptococcus faecalis MGH-21991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID206600In vitro antibacterial activity against gram-positive Staphylococcus aureus2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID198343Tested in vitro against Staphylococcus aureus FDA209P JC-1 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID210380In vitro antibacterial activity against gram-positive Streptococcus pneumoniae2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID63898Antibacterial activity was determined against gram negative organism, Enterobacter cloacae MA26461991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID69048Minimum concentration needed to produce linear DNA at an intensity relative to oxolinic at 10 ug/mL in Escherichia coli H560 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID65221Minimum inhibition concentration against Escherichia coli NIHJ JC-2 strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID52945In vitro antibacterial activity against gram-negative Citrobacter freundii2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID64254Antibacterial activity was determined against gram negative organism, E. coli(vogel)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID51918Mammalian cell cytotoxicity test in chinese hamster V79 cells (clonogenic cytotoxicity)1992Journal of medicinal chemistry, Dec-11, Volume: 35, Issue:25
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
AID71795Percentage of GABA-induced chloride currents with compound alone at 10 e-4 M1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID197875Minimum inhibition concentration against Staphylococcus aureus FDA209P strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID64404The in vivo potency was determined in female charles river CD-1 mice infected with Escherichia coli after peroral administration1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID205945Minimum inhibitory concentration (MIC) against gram positive bacteria Streptococcus pneumoniae SV-1.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID151373Antibacterial activity was determined against gram negative organism, Providencia rettgeri. (M1771)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID206890Antibacterial activity against Staphylococcus aureus UC761988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID117659In vivo potency against Streptococcus pneumoniae using mouse protection assay following p.o. administration.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID207975Minimum inhibitory concentration against Staphylococcus aureus UC-76 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID74729Compound evaluated in vitro against five gram-negative bacterial strains and geometric means of the minimum inhibitory concentrations (MIC) reported.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID96249In vitro antibacterial activity against Klebsiella pneumoniae 131990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID67532Minimum inhibitory concentration (MIC) against gram negative bacteria Enterobacter cloacae MA-2646.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID197880In vitro antibacterial activity against Staphylococcus aureus Smith (A9537)1989Journal of medicinal chemistry, Mar, Volume: 32, Issue:3
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
AID95916Antibacterial activity against Klebsiella pneumoniae MGH-21988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID94051Tested in vitro against Klebsiella pneumoniae PCI-602 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID165048In vitro antibacterial activity against Pseudomonas aeruginosa IFO 34451990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID53313Compound evaluated in vitro for the ability to inhibit gyrase.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID203106Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus H-228.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID117859Dose required to induce phototoxic reaction in 50% of mice by prolit reactions at different dosage forms1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID206877Antibacterial activity against Staphylococcus aureus H-2281988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID208766In vivo protection against gram-positive Streptococcus pneumonia (SV-1) in mouse after oral administration.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID209225In vitro antibacterial activity against Streptococcus faecalis 24731990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID164245Antibacterial activity against Pseudomonas aeruginosa UI-181988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID110152Percentage of mice with convulsion (400 mg/kg fenbufen)1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID151374Antibacterial activity was determined against gram negative organism, Providencia rettgeri. M17711991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID151670Minimum inhibition concentration against Pseudomonas aeruginosa U-31 strain1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID151530Tested in vivo against Pseudomonas aeruginosa E-2 in mice after peroral dose of drug with 0.5% sodium carboxy methyl cellulose1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID70926In vitro antibacterial activity against Escherichia coli P-51011990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID208301Minimum inhibitory concentration against Streptococcus pneumoniae SV-1 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID209894Antibacterial activity against Streptococcus pneumoniae SV-11988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID197877Antibacterial activity was determined against gram positive organism, Staphylococcus aureus H2281991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID209759Minimum inhibitory concentration against Streptococcus pyogenes C203 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID74723MIC ratio measured as the mean MICs of gram-negative bacteria1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID117655In vivo potency against Escherichia coli vogel using mouse protection assay when given subcutaneously1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID127505In vitro antibacterial activity against glucose nonfermenter Moraxella bovis P-71011990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID208767In vivo protection against gram-positive Streptococcus pneumonia (SV-1) in mouse after subcutaneous administration1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID163732Antibacterial activity against Providencia rettgeri M17711988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID7869250% inhibitory concentration against DNA-gyrase1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID117656In vivo potency against Staphylococcus aureus using mouse protection assay following p.o. administration.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID122563Dose which has no effect to induce phototoxic reaction in 50% of mice by probit method.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID165035In vitro antibacterial activity against Pseudomonas aeruginosa 121990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID70289In vivo protection against gram-positive Escherichia coli vogel in mouse after oral administration.1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
AID94001Antibacterial activity was determined against gram negative organism, Klebsiella pneumoniae MGH-21991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID71070Concentration required to produce linear DNA from closed circular DNA by the denaturation of the drug-gyrase-DNA complex1988Journal of medicinal chemistry, Mar, Volume: 31, Issue:3
7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.
AID40925Tested in vitro against Bacillus subtilis ATCC 6633 by agar dilution method1993Journal of medicinal chemistry, Sep-17, Volume: 36, Issue:19
Synthesis of antimicrobial agents. 5. In vivo metabolism of 7-(4-hydroxypiperazin-1-yl)quinolones.
AID200231Antibacterial activity was determined against gram positive organism, Staphylococcus aureus (UC76)1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID65234In vivo efficacy in mouse protection test in Escherichia coli Vogel administered by subcutaneous injection.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID74853Antibacterial activity against five Gram-positive bacteria targeting topoisomerase II (DNA gyrase B GyrB)1992Journal of medicinal chemistry, Dec-11, Volume: 35, Issue:25
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
AID197882Antibacterial activity was determined against gram positive organism, Staphylococcus aureus UC761991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship.
AID205745In vitro antibacterial activity against gram-positive Staphylococcus epidermidis2004Bioorganic & medicinal chemistry letters, Jan-19, Volume: 14, Issue:2
Synthesis and antibacterial activity of 7-(substituted)aminomethyl quinolones.
AID56590Days of the first positive reaction in depleted mice1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID71981Inhibition of [3H]muscimol binding to GABA A receptor with compound alone at 10 e-4 M1993Journal of medicinal chemistry, May-14, Volume: 36, Issue:10
Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships.
AID74727Antibacterial activity against five Gram-negative bacteria1992Journal of medicinal chemistry, Dec-11, Volume: 35, Issue:25
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity.
AID65235In vivo efficacy in mouse protection test in Escherichia coli Vogel dose administered orally by gavage.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID203107Minimum inhibitory concentration (MIC) against gram positive bacteria Staphylococcus aureus UC-76.1992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.
AID206284In vitro antibacterial activity against Staphylococcus aureus 507741990Journal of medicinal chemistry, Jun, Volume: 33, Issue:6
Synthesis and structure-activity relationships of 5-substituted 6,8-difluoroquinolones, including sparfloxacin, a new quinolone antibacterial agent with improved potency.
AID163051Minimum inhibitory concentration against Providencia rettgeri H1771 in vitro.1988Journal of medicinal chemistry, May, Volume: 31, Issue:5
Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
AID117653In vivo oral protective dose was determined in female charles river CD-1 mice infected with Streptococcus pneumoniae1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
AID230840MIC ratio measured as the mean MICs of gram-positive bacteria1991Journal of medicinal chemistry, Mar, Volume: 34, Issue:3
Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (23.08)18.7374
1990's9 (69.23)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.91 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]